Lisbon, Portugal • May 4-5, 2023

Longevity Med Summit

Scientific Advisory Board for 2023

Richard Siow, Director, Ageing Research at King´s College of London, Chair of the Scientific Advisory Board of the Longevity Med Summit

Since 2015, Richard has been the Director of Ageing Research at King´s (ARK), a cross-university Consortium of researchers taking a multidisciplinar approach to better understand the mechanism of ageing, improving health-span and the social and economic impact of ageing. He is an elected Fellow of the Royal Society of Biology, UK Lead for the International Society on Ageing & Disease, Committee Member of European Society for Microcirculation and Society for Free Radical Research – Europe.

Richard is the Specialty Chief Editor, Nutrition in Ageing and Healthy Longevity Section of Frontiers in Ageing, an Associative Editor of Frontiers in Genetic and Frontiers in Nutrition, a member of the Strategic Advisory Board of the ALL Party Parliamentary Group for Longevity and a member of the International Advisory Board of The Lancet Healthy Longevity.

Andrea B. Maier, Co-Director at Centre for Healthy Longevity, National University Health System, National University of Singapore, Singapore

Andrea Maier, a Fellow of the Royal Australasian College of Physicians (FRACP), graduated in Medicine (MD) 2003 from the University of Lübeck (Germany), was registered 2009 in the Netherlands as Specialist in Internal Medicine-Geriatrics and was appointed Full Professor of Gerontology at Vrije Universiteit Amsterdam (The Netherlands) in 2013. She was the head of Geriatrics at the Vrije Universiteit Medical Center from 2012 to 2016. From 2016 to early 2021 Professor Maier served as Divisional Director of Medicine and Community Care at the Royal Melbourne Hospital, Australia, and as Professor of Medicine and Aged Care at the University of Melbourne, Australia. She continued her career at the National University of Singapore as Co-Director of the Centre for Healthy Longevity.

Evelyne Bischof, MD, Chief Physician Associate of Internal Medicine and Oncology at University Hospital Renji of Jiatong University, Shangai, PRC

Dr. Bischof is a longevity physician integrating precision AI-based monitoring with deep aging analysis and individualized therapies to help patients achieve healthy longevity and optimal performance. A Harvard-and Columbia-trained physician and author of over 80 peer-reviewed papers. She is passionate about next-generation medical technology, and the applications of AI for biomedical research and practice, digital health and innovative technology. Dr. Bischof sits on several scientific and advisory boards for biotech and longevity hubs.Dr. Bishof is a frequent speaker at scientific and medical conferences in Asia and Europe. Long term member of various medical societies, e.g. European Federation of Internal Medicine, World Academy of Medical Sciences, Swiss Society of Internal Medicine.

Dr. Eric Verdin, President & CEO Buck Institute for Research on Aging Novato, CA, USA

Dr. Eric Verdin is the President and CEO of the Buck Institute for Research on Aging – a pioneering biomedical research institute dedicated to ageing and age-related disease. A native of Belgium, Dr. Verdin received his Doctorate of Medicine (MD) from the University of Liege and completed additional clinical and research training at Harvard Medical School. He has held faculty positions at the University of Brussels, the National Institutes of Health (NIH), and the Picower Institute for Medical Research. Dr. Verdin is also currently a professor of medicine at the University of California, San Francisco. He joined the Gladstone Institute of Virology and Immunology in 1997, becoming the associate director in 2004. In 2016 Dr. Verdin established his laboratory at the Buck Institute for Research on Aging to study the relationship between ageing and the immune system. He is in the top one percent of cited scientists and has been recognized for his research with a Glenn Award for Research in Biological Mechanisms of Aging and a senior scholarship from the Ellison Medical Foundation. He has published more than 220 scientific papers and holds more than 15 patents. He is an elected member of several scientific organizations, including the American Association for the Advancement of Science, the American Society for Clinical Investigation, and the Association of American Physicians. He also serves on the advisory council of the National Institute on Drug Abuse at the National Institutes of Health. Dr. Verdin has extensive experience working with biotech companies, including Novartis, Roche, Pfizer, and now Hooke London.

Philipp Gut, Head of Data Sciences and Precision Nutrition, Nestlé Institute of Health Sciences, Lausanne, Switzerland

Philipp is Head of Data Sciences and Precision Nutrition at the Nestlé Institute of Health Sciences, which is part of Nestlé’s extensive R&D Network. Over the past years, he has led a translational research program in healthy aging that brings to life nutritional solutions for disease prevention and management of chronic conditions across the Nestlé portfolio. Current work combines biomarkers, smart nutrition profiling and digital ecosystems that enable people to take informed health and nutrition choices and help track success of personalized nutrition interventions. Philipp graduated from Heidelberg Medical School in Germany prior to postdoctoral studies on molecular mechanisms of aging at the University of California and the Gladstone Institutes in San Francisco, USA.

Matt Kaeberlein, PhD, Professor of Genome Sciences, University of Washington, Seattle, WA, USA

The Matt Kaeberlein contributions have also been recognized with Fellow status in the American Association for the Advancement of Science, the American Aging Association, and the Gerontological Society of America. Dr. Kaeberlein is a past President of the American Aging Association and has served on their Executive Committee and Board of Directors since 2012. He is also a former member of the Board of Directors for the Federation of American Societies for Biology and the current Chair of the Biological Sciences Section of the Gerontological Society of America. Dr. Kaeberlein is Founding Director of the Healthy Aging and Longevity Research Institute at the University of Washington, Director of the Nathan Shock Center of Excellence in the Basic Biology of Aging, Director of the Biological Mechanisms of Healthy Aging Training Program, and co-Director of the Dog Aging Project.